Synthesis and Evaluation of Targeted Prodrugs for Cancer Treatment

Synthesis and Evaluation of Targeted Prodrugs for Cancer Treatment


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 5,066

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

The Drug delivery system (DDS) consisted of several combination's of the anticancer drug doxorubicin (DOX), polymeric drug carrier polyethylene glycol (PEG), drug spacer citric acid (CA) and targeting moiety sialic acid (SA) which was evaluated in vitro for cytotoxicity on human ovarian carcinoma cells (A2780). The targeted prodrug conjugates with two copies of SA and DOX showed enhanced cytotoxicity when compared with non-targeted prodrugs and free DOX. Targeting of the conjugate to cancer cells by sialic acid and an increase in number of copies of targeting moiety and anticancer drug enhanced prodrug uptake by cancer cells and cytotoxicity of the prodrug. Analysis of synthesized conjugates by 1NMR, MALDI/TOF, and HPLC showed the formation of the PEG prodrugs. More than 40% of the drug was released from its conjugate in presence of esterase enzyme, whereas the conjugate was stable at pH 7.4. The data obtained suggest that PAMAM G4-SA dendrimer represents a promising vehicle for intracellular delivery of low solubility drugs such as paclitaxel. Developed dendrimer provides both cytoplasmic and nuclear delivery of therapeutics and enhances anticancer activity of paclitaxel.

Product Specifications
SKU :COC31002
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-31
0 Review(s)